Literature DB >> 19359249

Substrate recognition of anthrax lethal factor examined by combinatorial and pre-steady-state kinetic approaches.

Maria Yu Zakharova1, Nikita A Kuznetsov, Svetlana A Dubiley, Arina V Kozyr, Olga S Fedorova, Dmitry M Chudakov, Dmitry G Knorre, Igor G Shemyakin, Alexander G Gabibov, Alexander V Kolesnikov.   

Abstract

Lethal factor (LF), a zinc-dependent protease of high specificity produced by Bacillus anthracis, is the effector component of the binary toxin that causes death in anthrax. New therapeutics targeting the toxin are required to reduce systemic anthrax-related fatalities. In particular, new insights into the LF catalytic mechanism will be useful for the development of LF inhibitors. We evaluated the minimal length required for formation of bona fide LF substrates using substrate phage display. Phage-based selection yielded a substrate that is cleaved seven times more efficiently by LF than the peptide targeted in the protein kinase MKK6. Site-directed mutagenesis within the metal-binding site in the LF active center and within phage-selected substrates revealed a complex pattern of LF-substrate interactions. The elementary steps of LF-mediated proteolysis were resolved by the stopped-flow technique. Pre-steady-state kinetics of LF proteolysis followed a four-step mechanism as follows: initial substrate binding, rearrangement of the enzyme-substrate complex, a rate-limiting cleavage step, and product release. Examination of LF interactions with metal ions revealed an unexpected activation of the protease by Ca(2+) and Mn(2+). Based on the available structural and kinetic data, we propose a model for LF-substrate interaction. Resolution of the kinetic and structural parameters governing LF activity may be exploited to design new LF inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359249      PMCID: PMC2709388          DOI: 10.1074/jbc.M807510200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Anthrax inhalation and lethal human infection.

Authors:  Franz Allerberger; Katharina Grif; Manfred P Dierich; Andreas Wimmer; Helga Plicka
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

3.  A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease.

Authors:  Richard T Cummings; Scott P Salowe; Barry R Cunningham; Judyann Wiltsie; Young Whan Park; Lisa M Sonatore; Douglas Wisniewski; Cameron M Douglas; Jeffrey D Hermes; Edward M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 4.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

5.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

Authors:  T Schindler; W Bornmann; P Pellicena; W T Miller; B Clarkson; J Kuriyan
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

Review 6.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

7.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.

Authors:  W R Scott; C A Schiffer
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

8.  Screening inhibitors of anthrax lethal factor.

Authors:  Fiorella Tonello; Michela Seveso; Oriano Marin; Michèle Mock; Cesare Montecucco
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Anthrax lethal factor proteolysis and inactivation of MAPK kinase.

Authors:  Arun P Chopra; Sherrie A Boone; Xudong Liang; Nicholas S Duesbery
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

10.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more
  6 in total

1.  Pre-steady-state kinetics of interaction of wild-type and multiple drug-resistant HIV protease with first and second generation inhibitory drugs.

Authors:  N A Kuznetsov; A V Kozyr; M A Dronina; I V Smirnov; E N Kaliberda; A G Mikhailova; L D Rumsh; O S Fedorova; A G Gabibov; A V Kolesnikov
Journal:  Dokl Biochem Biophys       Date:  2011-11-19       Impact factor: 0.788

Review 2.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

Review 3.  New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.

Authors:  J M Beierlein; A C Anderson
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.

Authors:  Maria Yu Zakharova; Alexandra A Kuznetsova; Victoria I Uvarova; Anastasiia D Fomina; Liubov I Kozlovskaya; Elena N Kaliberda; Inna N Kurbatskaia; Ivan V Smirnov; Anatoly A Bulygin; Vera D Knorre; Olga S Fedorova; Alexandre Varnek; Dmitry I Osolodkin; Aydar A Ishmukhametov; Alexey M Egorov; Alexander G Gabibov; Nikita A Kuznetsov
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

5.  Mechanism of Action of Monoclonal Antibodies That Block the Activity of the Lethal Toxin of Bacillus Anthracis.

Authors:  Ya O Romanenko; A K Riabko; M A Marin; A S Kartseva; M V Silkina; I G Shemyakin; V V Firstova
Journal:  Acta Naturae       Date:  2021 Oct-Dec       Impact factor: 1.845

6.  Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor.

Authors:  Joseph Chavarría-Smith; Russell E Vance
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.